Coppell Advisory Solutions Corp’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,190	Closed	-$42.3K	–	491
2022 Q4	$42.3K	Buy	+4,190	New	+$42.3K	0.01%	375